Literature DB >> 5125181

Rifampin alone and combined with other drugs in Mycobacterium kansasii and Mycobacterium intracellulare infections of mice.

J S Shronts, T K Rynearson, E Wolinsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5125181     DOI: 10.1164/arrd.1971.104.5.728

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


× No keyword cloud information.
  4 in total

1.  In vivo activities of newer rifamycin analogs against Mycobacterium avium infection.

Authors:  S P Klemens; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

Review 2.  Beige mouse model for Mycobacterium avium complex disease.

Authors:  P R Gangadharam
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

3.  Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice.

Authors:  M H Cynamon; C E Swenson; G S Palmer; R S Ginsberg
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  The effect of combined chemotherapy on suppressor T-cell activity in Mycobacterium simiae-infected mice.

Authors:  S R Watson; L K Auclair; F M Collins
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.